Steroid injections are human-made drugs similar to cortisol, a hormone in the human body in adrenal glands. It can be called as cortisone injections, cortisone shots, steroid shots, or corticosteroid injections. Steroids ease inflammation and slow the immune system. They can treat various kinds of inflammatory conditions.
Steroid injections are often recommended for patients with rheumatoid arthritis and many types of inflammatory arthritis. They may be recommended for osteoarthritis if joints are very painful or require extra pain relief for a time. The injection can lower inflammation, which in turn should decrease pain. Several different steroids are available for injection. Common examples of steroid injections are hydrocortisone, triamcinolone, and methylprednisolone.
MARKET DYNAMICS
Factors driving the growth of the steroid Injection market are the growing prevalence of bone and joint diseases, coupled with advancement in steroid injection treatment. However, the stringent regulation and adverse effects of the product are expected to hamper the growth of the market. Moreover, a rise in demand for steroid injections and the growing number of obese people worldwide is anticipated to boost the market growth.
MARKET SCOPE
The "Steroid Injections Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of steroid injections market with detailed market segmentation by product type, route of administration, and distribution channel. The steroid injections market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in steroid injections market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The steroid injections market is segmented on the basis of product type, route of administration, and distribution channel. Based on product type, the market is segmented as prednisolone, triamcinolone, prednisone, methylprednisolone, and dexamethasone. On the basis of route of administration, the market is categorized as intramuscular, intra-articular, intravenous, and epidural. On the basis of distribution channel, the market is categorized as hospital pharmacy, specialty clinics, retail pharmacy & drug stores, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the steroid injections market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The steroid injections market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting steroid injections market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the steroid injections market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the steroid injections market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The steroid injections market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting steroid injections market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the steroid injections market in these regions.
MARKET PLAYERS
The report covers key developments in the steroid injections market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from steroid injections market are anticipated to have lucrative growth opportunities in the future with the rising demand for steroid injections in the global market. Below mentioned is the list of few companies engaged in the steroid injections market.
The report also includes the profiles of key players in steroid injections market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Bristol-Myers Squibb Company
- Scintilla Pharmaceuticals, Inc.
- Flexion Therapeutics, Inc.
- Pfizer, Inc.
- Mylan N.V.
- EIPICO
- Concordia International Rx UK Ltd.
- Intrapharm Laboratories Limited Company
- Advanz Pharma
- Flagship Biotech International Private Limited.
- Health Biotech Limited
- Others
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Softgel Capsules Market - By Product Type
1.3.2 Softgel Capsules Market - By Raw Material
1.3.3 Softgel Capsules Market - By Application
1.3.4 Softgel Capsules Market - By End User
1.3.5 Softgel Capsules Market - By Region
1.3.5.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SOFTGEL CAPSULES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SOFTGEL CAPSULES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SOFTGEL CAPSULES MARKET - GLOBAL MARKET ANALYSIS
6.1. SOFTGEL CAPSULES - GLOBAL MARKET OVERVIEW
6.2. SOFTGEL CAPSULES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. SOFTGEL CAPSULES MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. GELATIN SOFTGEL CAPSULES
7.3.1. Overview
7.3.2. Gelatin Softgel Capsules Market Forecast and Analysis
7.4. VEGETARIAN SOFTGEL CAPSULES
7.4.1. Overview
7.4.2. Vegetarian Softgel Capsules Market Forecast and Analysis
8. SOFTGEL CAPSULES MARKET - REVENUE AND FORECASTS TO 2028 - RAW MATERIAL
8.1. OVERVIEW
8.2. RAW MATERIAL MARKET FORECASTS AND ANALYSIS
8.3. TYPE-A GELATIN (PORK SKIN)
8.3.1. Overview
8.3.2. Type-A Gelatin (Pork Skin) Market Forecast and Analysis
8.4. TYPE-B GELATIN (ANIMAL BONES & CALF SKIN)
8.4.1. Overview
8.4.2. Type-B Gelatin (Animal Bones & Calf Skin) Market Forecast and Analysis
8.5. FISH BONE GELATIN
8.5.1. Overview
8.5.2. Fish Bone Gelatin Market Forecast and Analysis
8.6. HYDROXY PROPYL METHYL CELLULOSE (HPMC)
8.6.1. Overview
8.6.2. Hydroxy Propyl Methyl Cellulose (HPMC) Market Forecast and Analysis
8.7. STARCH MATERIAL
8.7.1. Overview
8.7.2. Starch Material Market Forecast and Analysis
8.8. PULLULAN
8.8.1. Overview
8.8.2. Pullulan Market Forecast and Analysis
9. SOFTGEL CAPSULES MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. ANTACID & ANTIFLATULENT PREPARATIONS
9.3.1. Overview
9.3.2. Antacid & Antiflatulent Preparations Market Forecast and Analysis
9.4. ANTIANEMIC PREPARATIONS (HEMATENIC PREPARATIONS)
9.4.1. Overview
9.4.2. Antianemic Preparations (Hematenic Preparations) Market Forecast and Analysis
9.5. ANTI-INFLAMMATORY DRUGS
9.5.1. Overview
9.5.2. Anti-inflammatory Drugs Market Forecast and Analysis
9.6. ANTIBIOTIC & ANTIBACTERIAL DRUGS
9.6.1. Overview
9.6.2. Antibiotic & Antibacterial Drugs Market Forecast and Analysis
9.7. COUGH & COLD PREPARATIONS
9.7.1. Overview
9.7.2. Cough & Cold Preparations Market Forecast and Analysis
9.8. CARDIOVASCULAR THERAPY DRUGS
9.8.1. Overview
9.8.2. Cardiovascular Therapy Drugs Market Forecast and Analysis
9.9. VITAMIN AND DIETARY SUPPLEMENTS
9.9.1. Overview
9.9.2. Vitamin and Dietary Supplements Market Forecast and Analysis
9.10. OTHERS
9.10.1. Overview
9.10.2. Others Market Forecast and Analysis
10. SOFTGEL CAPSULES MARKET - REVENUE AND FORECASTS TO 2028 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. PHARMACEUTICAL COMPANIES
10.3.1. Overview
10.3.2. Pharmaceutical Companies Market Forecast and Analysis
10.4. NUTRACEUTICAL COMPANIES
10.4.1. Overview
10.4.2. Nutraceutical Companies Market Forecast and Analysis
10.5. COSMECEUTICAL COMPANIES
10.5.1. Overview
10.5.2. Cosmeceutical Companies Market Forecast and Analysis
10.6. CONTRACT MANUFACTURING ORGANIZATIONS
10.6.1. Overview
10.6.2. Contract Manufacturing Organizations Market Forecast and Analysis
11. SOFTGEL CAPSULES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Softgel Capsules Market Overview
11.1.2 North America Softgel Capsules Market Forecasts and Analysis
11.1.3 North America Softgel Capsules Market Forecasts and Analysis - By Product Type
11.1.4 North America Softgel Capsules Market Forecasts and Analysis - By Raw Material
11.1.5 North America Softgel Capsules Market Forecasts and Analysis - By Application
11.1.6 North America Softgel Capsules Market Forecasts and Analysis - By End User
11.1.7 North America Softgel Capsules Market Forecasts and Analysis - By Countries
11.1.7.1 United States Softgel Capsules Market
11.1.7.1.1 United States Softgel Capsules Market by Product Type
11.1.7.1.2 United States Softgel Capsules Market by Raw Material
11.1.7.1.3 United States Softgel Capsules Market by Application
11.1.7.1.4 United States Softgel Capsules Market by End User
11.1.7.2 Canada Softgel Capsules Market
11.1.7.2.1 Canada Softgel Capsules Market by Product Type
11.1.7.2.2 Canada Softgel Capsules Market by Raw Material
11.1.7.2.3 Canada Softgel Capsules Market by Application
11.1.7.2.4 Canada Softgel Capsules Market by End User
11.1.7.3 Mexico Softgel Capsules Market
11.1.7.3.1 Mexico Softgel Capsules Market by Product Type
11.1.7.3.2 Mexico Softgel Capsules Market by Raw Material
11.1.7.3.3 Mexico Softgel Capsules Market by Application
11.1.7.3.4 Mexico Softgel Capsules Market by End User
11.1.7.4 US Softgel Capsules Market
11.1.7.4.1 US Softgel Capsules Market by Product Type
11.1.7.4.2 US Softgel Capsules Market by Raw Material
11.1.7.4.3 US Softgel Capsules Market by Application
11.1.7.4.4 US Softgel Capsules Market by End User
11.2. EUROPE
11.2.1 Europe Softgel Capsules Market Overview
11.2.2 Europe Softgel Capsules Market Forecasts and Analysis
11.2.3 Europe Softgel Capsules Market Forecasts and Analysis - By Product Type
11.2.4 Europe Softgel Capsules Market Forecasts and Analysis - By Raw Material
11.2.5 Europe Softgel Capsules Market Forecasts and Analysis - By Application
11.2.6 Europe Softgel Capsules Market Forecasts and Analysis - By End User
11.2.7 Europe Softgel Capsules Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Softgel Capsules Market
11.2.7.1.1 Germany Softgel Capsules Market by Product Type
11.2.7.1.2 Germany Softgel Capsules Market by Raw Material
11.2.7.1.3 Germany Softgel Capsules Market by Application
11.2.7.1.4 Germany Softgel Capsules Market by End User
11.2.7.2 France Softgel Capsules Market
11.2.7.2.1 France Softgel Capsules Market by Product Type
11.2.7.2.2 France Softgel Capsules Market by Raw Material
11.2.7.2.3 France Softgel Capsules Market by Application
11.2.7.2.4 France Softgel Capsules Market by End User
11.2.7.3 Italy Softgel Capsules Market
11.2.7.3.1 Italy Softgel Capsules Market by Product Type
11.2.7.3.2 Italy Softgel Capsules Market by Raw Material
11.2.7.3.3 Italy Softgel Capsules Market by Application
11.2.7.3.4 Italy Softgel Capsules Market by End User
11.2.7.4 Spain Softgel Capsules Market
11.2.7.4.1 Spain Softgel Capsules Market by Product Type
11.2.7.4.2 Spain Softgel Capsules Market by Raw Material
11.2.7.4.3 Spain Softgel Capsules Market by Application
11.2.7.4.4 Spain Softgel Capsules Market by End User
11.2.7.5 United Kingdom Softgel Capsules Market
11.2.7.5.1 United Kingdom Softgel Capsules Market by Product Type
11.2.7.5.2 United Kingdom Softgel Capsules Market by Raw Material
11.2.7.5.3 United Kingdom Softgel Capsules Market by Application
11.2.7.5.4 United Kingdom Softgel Capsules Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Softgel Capsules Market Overview
11.3.2 Asia-Pacific Softgel Capsules Market Forecasts and Analysis
11.3.3 Asia-Pacific Softgel Capsules Market Forecasts and Analysis - By Product Type
11.3.4 Asia-Pacific Softgel Capsules Market Forecasts and Analysis - By Raw Material
11.3.5 Asia-Pacific Softgel Capsules Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Softgel Capsules Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Softgel Capsules Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Softgel Capsules Market
11.3.7.1.1 Australia Softgel Capsules Market by Product Type
11.3.7.1.2 Australia Softgel Capsules Market by Raw Material
11.3.7.1.3 Australia Softgel Capsules Market by Application
11.3.7.1.4 Australia Softgel Capsules Market by End User
11.3.7.2 China Softgel Capsules Market
11.3.7.2.1 China Softgel Capsules Market by Product Type
11.3.7.2.2 China Softgel Capsules Market by Raw Material
11.3.7.2.3 China Softgel Capsules Market by Application
11.3.7.2.4 China Softgel Capsules Market by End User
11.3.7.3 India Softgel Capsules Market
11.3.7.3.1 India Softgel Capsules Market by Product Type
11.3.7.3.2 India Softgel Capsules Market by Raw Material
11.3.7.3.3 India Softgel Capsules Market by Application
11.3.7.3.4 India Softgel Capsules Market by End User
11.3.7.4 Japan Softgel Capsules Market
11.3.7.4.1 Japan Softgel Capsules Market by Product Type
11.3.7.4.2 Japan Softgel Capsules Market by Raw Material
11.3.7.4.3 Japan Softgel Capsules Market by Application
11.3.7.4.4 Japan Softgel Capsules Market by End User
11.3.7.5 South Korea Softgel Capsules Market
11.3.7.5.1 South Korea Softgel Capsules Market by Product Type
11.3.7.5.2 South Korea Softgel Capsules Market by Raw Material
11.3.7.5.3 South Korea Softgel Capsules Market by Application
11.3.7.5.4 South Korea Softgel Capsules Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Softgel Capsules Market Overview
11.4.2 Middle East and Africa Softgel Capsules Market Forecasts and Analysis
11.4.3 Middle East and Africa Softgel Capsules Market Forecasts and Analysis - By Product Type
11.4.4 Middle East and Africa Softgel Capsules Market Forecasts and Analysis - By Raw Material
11.4.5 Middle East and Africa Softgel Capsules Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Softgel Capsules Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Softgel Capsules Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Softgel Capsules Market
11.4.7.1.1 South Africa Softgel Capsules Market by Product Type
11.4.7.1.2 South Africa Softgel Capsules Market by Raw Material
11.4.7.1.3 South Africa Softgel Capsules Market by Application
11.4.7.1.4 South Africa Softgel Capsules Market by End User
11.4.7.2 Saudi Arabia Softgel Capsules Market
11.4.7.2.1 Saudi Arabia Softgel Capsules Market by Product Type
11.4.7.2.2 Saudi Arabia Softgel Capsules Market by Raw Material
11.4.7.2.3 Saudi Arabia Softgel Capsules Market by Application
11.4.7.2.4 Saudi Arabia Softgel Capsules Market by End User
11.4.7.3 U.A.E Softgel Capsules Market
11.4.7.3.1 U.A.E Softgel Capsules Market by Product Type
11.4.7.3.2 U.A.E Softgel Capsules Market by Raw Material
11.4.7.3.3 U.A.E Softgel Capsules Market by Application
11.4.7.3.4 U.A.E Softgel Capsules Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Softgel Capsules Market Overview
11.5.2 South and Central America Softgel Capsules Market Forecasts and Analysis
11.5.3 South and Central America Softgel Capsules Market Forecasts and Analysis - By Product Type
11.5.4 South and Central America Softgel Capsules Market Forecasts and Analysis - By Raw Material
11.5.5 South and Central America Softgel Capsules Market Forecasts and Analysis - By Application
11.5.6 South and Central America Softgel Capsules Market Forecasts and Analysis - By End User
11.5.7 South and Central America Softgel Capsules Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Softgel Capsules Market
11.5.7.1.1 Brazil Softgel Capsules Market by Product Type
11.5.7.1.2 Brazil Softgel Capsules Market by Raw Material
11.5.7.1.3 Brazil Softgel Capsules Market by Application
11.5.7.1.4 Brazil Softgel Capsules Market by End User
11.5.7.2 Argentina Softgel Capsules Market
11.5.7.2.1 Argentina Softgel Capsules Market by Product Type
11.5.7.2.2 Argentina Softgel Capsules Market by Raw Material
11.5.7.2.3 Argentina Softgel Capsules Market by Application
11.5.7.2.4 Argentina Softgel Capsules Market by End User
12. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SOFTGEL CAPSULES MARKET
12.1 North America
12.2 Europe
12.3 Asia-Pacific
12.4 Rest of the World
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. SOFTGEL CAPSULES MARKET, KEY COMPANY PROFILES
14.1. AENOVA GROUP GMBH
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. HUNAN ER-KANG PHARMACEUTICAL CO., LTD
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. CAPSUGEL
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. FUJI CAPSULE CO., LTD.
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. SIRIO PHARMA COMPANY LIMITED
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. CAPTEK SOFTGEL INTERNATIONAL INC
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. CATALENT, INC.
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. EUROCAPS LTD (PART OF DCC PLC)
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. GUANGDONG YICHAO BIOLOGICAL CO., LTD
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. ELNOVA PHARMA
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
14.11. OTHERS
14.11.1. Key Facts
14.11.2. Business Description
14.11.3. Products and Services
14.11.4. Financial Overview
14.11.5. SWOT Analysis
14.11.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
1. Bristol-Myers Squibb Company
2. Scintilla Pharmaceuticals, Inc.
3. Flexion Therapeutics, Inc.
4. Pfizer, Inc.
5. Mylan N.V.
6. EIPICO
7. Concordia International Rx UK Ltd.
8. Intrapharm Laboratories Limited Company
9. Advanz Pharma
10. Flagship Biotech International Private Limited.
11. Health Biotech Limited
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For